Skip to main content
Erschienen in: Annals of Surgical Oncology 2/2019

27.11.2018 | Hepatobiliary Tumors

Higher Tumor Burden Neutralizes Negative Margin Status in Hepatectomy for Colorectal Cancer Liver Metastasis

verfasst von: Masanori Oshi, MD, Georgios Antonios Margonis, MD, PhD, Yu Sawada, MD, PhD, Nikolaos Andreatos, MD, Jin He, MD, PhD, Takafumi Kumamoto, MD, PhD, Daisuke Morioka, MD, PhD, Christopher Lee Wolfgang, MD, PhD, Kuniya Tanaka, MD, PhD, Matthew John Weiss, MD, Itaru Endo, MD, PhD

Erschienen in: Annals of Surgical Oncology | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Abstract

Objective

The aim of this study was to examine if the prognostic significance of margin status in hepatectomy for colorectal cancer liver metastasis (CRLM) varies for different levels of tumor burden because hepatectomy indications for CRLM have been recently expanded to include patients with a higher tumor burden in whom achieving an R0 resection is difficult.

Methods

Clinicopathological variables in an exploration cohort of 290 patients receiving hepatectomy in Japan for CRLM were investigated. R0 resection was defined as a margin width > 0 mm. Tumor burden was assessed using the recently introduced Tumor Burden Score (TBS), which was calculated as TBS2 = (maximum tumor diameter in cm)2 + (number of lesions)2. The principal findings were validated using a cohort from the United States.

Results

R1 resection rates significantly increased as TBS increased: 4/86 (4.7%) in patients with TBS < 3, 29/171 (17.0%) in patients with TBS ≥ 3 and < 9, and 9/33 (27.3%) in patients with TBS ≥ 9 (p < 0.001). R0 resection was significantly superior to R1 resection in patients with TBS ≥ 5; however, this was not the case for TBS ≥ 6, as confirmed by both univariate and multivariate analyses. Furthermore, prehepatectomy chemotherapy was associated with significantly improved survival for patients with TBS ≥ 8. Analysis of the validation cohort yielded similar results.

Conclusions

R0 resection appeared to have a positive impact on prognosis among patients with low tumor burden; however, this was not the case for patients with high tumor burden. As such, systemic treatment, in addition to surgery, may be central to achieving satisfactory outcomes in the latter patient population.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Ekberg H, Tranberg KG, Andersson R, Lundstedt C, Hagerstrand I, Ranstam J, et al. Determinants of survival in liver resection for colorectal secondaries. Br J Surg. 1986;73:727–731.CrossRefPubMed Ekberg H, Tranberg KG, Andersson R, Lundstedt C, Hagerstrand I, Ranstam J, et al. Determinants of survival in liver resection for colorectal secondaries. Br J Surg. 1986;73:727–731.CrossRefPubMed
2.
Zurück zum Zitat Shirabe K, Takenaka K, Gion T, Fujiwara Y, Shimada M, Yanaga K, et al. Analysis of prognostic risk factors in hepatic resection for metastatic colorectal carcinoma with special reference to the surgical margin. Br J Surg. 1997;84:1077–1080.CrossRefPubMed Shirabe K, Takenaka K, Gion T, Fujiwara Y, Shimada M, Yanaga K, et al. Analysis of prognostic risk factors in hepatic resection for metastatic colorectal carcinoma with special reference to the surgical margin. Br J Surg. 1997;84:1077–1080.CrossRefPubMed
3.
Zurück zum Zitat Kokudo N, Miki Y, Sugai S, Yanagisawa A, Kato Y, Sakamoto Y, et al. Genetic and histological assessment of surgical margins in resected liver metastases from colorectal carcinoma. Arch Surg. 2002;137:833–840.CrossRefPubMed Kokudo N, Miki Y, Sugai S, Yanagisawa A, Kato Y, Sakamoto Y, et al. Genetic and histological assessment of surgical margins in resected liver metastases from colorectal carcinoma. Arch Surg. 2002;137:833–840.CrossRefPubMed
4.
Zurück zum Zitat Are C, Gonen M, Zazzali K, DeMatteo RP, Jarnagin WR, Fong Y, et al. The impact of margins on outcome after hepatic reseection for colorectal metastasis. Ann Surg. 2007;246:295–300.CrossRefPubMedPubMedCentral Are C, Gonen M, Zazzali K, DeMatteo RP, Jarnagin WR, Fong Y, et al. The impact of margins on outcome after hepatic reseection for colorectal metastasis. Ann Surg. 2007;246:295–300.CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Wakai T, Shirai Y, Sakata J, Valera VA, Korita PV, Akazawa K, et al. Appraisal of 1 cm hepatectomy margin for intrahepatic micrometastases in patients with colorectal carcinoma liver metastasis. Ann Surg Oncol. 2008;15:2472–2481.CrossRefPubMed Wakai T, Shirai Y, Sakata J, Valera VA, Korita PV, Akazawa K, et al. Appraisal of 1 cm hepatectomy margin for intrahepatic micrometastases in patients with colorectal carcinoma liver metastasis. Ann Surg Oncol. 2008;15:2472–2481.CrossRefPubMed
6.
Zurück zum Zitat Nuzzo G, Giulante F, Ardito F, Vellone M, Giovannini I, Federico B, et al. Influence of surgical margin on type or recurrence after liver resection for colorectal metastases: a single-center experience. Surgery. 2008;143:384–393.CrossRefPubMed Nuzzo G, Giulante F, Ardito F, Vellone M, Giovannini I, Federico B, et al. Influence of surgical margin on type or recurrence after liver resection for colorectal metastases: a single-center experience. Surgery. 2008;143:384–393.CrossRefPubMed
7.
Zurück zum Zitat Gomez D, Morris-Stiff G, Wyatt J, Toogood GJ, Lodge JPA, Prasad KR. Surgical technique and systemic inflammation influences long-term disease-free survival following hepatic resection for colorectal metastasis. J Surg Oncol. 2008;98:371–376.CrossRefPubMed Gomez D, Morris-Stiff G, Wyatt J, Toogood GJ, Lodge JPA, Prasad KR. Surgical technique and systemic inflammation influences long-term disease-free survival following hepatic resection for colorectal metastasis. J Surg Oncol. 2008;98:371–376.CrossRefPubMed
8.
Zurück zum Zitat Vandeweyer D, Neo EL, Chen JWC, Maddern GJ, Wilson TG, Padbury RTA. Influence of resection margin on survival in hepatic resection for colorectal liver metastases. HPB (Oxford). 2009;11:499–504.CrossRefPubMedCentral Vandeweyer D, Neo EL, Chen JWC, Maddern GJ, Wilson TG, Padbury RTA. Influence of resection margin on survival in hepatic resection for colorectal liver metastases. HPB (Oxford). 2009;11:499–504.CrossRefPubMedCentral
9.
Zurück zum Zitat Nanashima A, Araki M, Tobinaga S, Kunizaki M, Hidaka S, Shibata K, et al. Relationship between period of survival and clinicopathological characteristics in patients with colorectal liver metastasis. Eur J Surg Oncol. 2009;35:504–509.CrossRefPubMed Nanashima A, Araki M, Tobinaga S, Kunizaki M, Hidaka S, Shibata K, et al. Relationship between period of survival and clinicopathological characteristics in patients with colorectal liver metastasis. Eur J Surg Oncol. 2009;35:504–509.CrossRefPubMed
10.
Zurück zum Zitat Dhir M, Lyden ER, Wang A, Smith LM, Ullrich F, Are C. Influence of margins on overall survival after hepatic resection for colorectal metastasis: a meta-analysis. Ann Surg. 2011;254:234–242.CrossRefPubMed Dhir M, Lyden ER, Wang A, Smith LM, Ullrich F, Are C. Influence of margins on overall survival after hepatic resection for colorectal metastasis: a meta-analysis. Ann Surg. 2011;254:234–242.CrossRefPubMed
11.
Zurück zum Zitat Tranchart H, Chirica M, Faron M, Balladur P, Lefevre LB, Svrcek M, et al. Prognostic impact of positive surgical margins after resection of colorectal cancer liver metastasis: reappraisal in the era of modern chemotherapy. World J Surg. 2013;37:2647–2654.CrossRefPubMed Tranchart H, Chirica M, Faron M, Balladur P, Lefevre LB, Svrcek M, et al. Prognostic impact of positive surgical margins after resection of colorectal cancer liver metastasis: reappraisal in the era of modern chemotherapy. World J Surg. 2013;37:2647–2654.CrossRefPubMed
12.
Zurück zum Zitat Andreou A, Aloia TA, Brouquet A, Dickson PV, Zimmitti G, Maru DM, et al. Margin status remains an important determinant of survival after surgical resection of colorectal liver metastases in the era of modern chemotherapy. Ann Surg. 2013;257:1079–1088.CrossRefPubMedPubMedCentral Andreou A, Aloia TA, Brouquet A, Dickson PV, Zimmitti G, Maru DM, et al. Margin status remains an important determinant of survival after surgical resection of colorectal liver metastases in the era of modern chemotherapy. Ann Surg. 2013;257:1079–1088.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat John SKP, Robinson SM, Rehman S, Harrison B, Vallace A, French JJ, et al. Prognostic factors and survival after resection of colorectal liver metastasis in the era of preoperative chemotherapy: an 11-year single-centre study. Dig Surg. 2013;30:293–301.CrossRefPubMed John SKP, Robinson SM, Rehman S, Harrison B, Vallace A, French JJ, et al. Prognostic factors and survival after resection of colorectal liver metastasis in the era of preoperative chemotherapy: an 11-year single-centre study. Dig Surg. 2013;30:293–301.CrossRefPubMed
14.
Zurück zum Zitat Liu W, Sun Y, Xing BC. Negative surgical margin improved long-term survival of colorectal cancer liver metastases after hepatic resection: a systematic review and meta-analysis. Int J Colorectal Dis. 2015;30:1365–1373.CrossRefPubMed Liu W, Sun Y, Xing BC. Negative surgical margin improved long-term survival of colorectal cancer liver metastases after hepatic resection: a systematic review and meta-analysis. Int J Colorectal Dis. 2015;30:1365–1373.CrossRefPubMed
15.
Zurück zum Zitat de Haas RJ, Wicherts DA, Flores E, Azoulay D, Casting D, Adam R. R1 resection by necessity for colorectal liver metastases: is it still a contraindication to surgery? Ann Surg. 2008;248:626–637.PubMed de Haas RJ, Wicherts DA, Flores E, Azoulay D, Casting D, Adam R. R1 resection by necessity for colorectal liver metastases: is it still a contraindication to surgery? Ann Surg. 2008;248:626–637.PubMed
16.
Zurück zum Zitat Poultsides GA, Schulick RD, Pawlik TM. Hepatic resection for colorectal metastases: the impact of surgical margin status on outcome. HPB (Oxford). 2010;12:43–49.CrossRef Poultsides GA, Schulick RD, Pawlik TM. Hepatic resection for colorectal metastases: the impact of surgical margin status on outcome. HPB (Oxford). 2010;12:43–49.CrossRef
17.
Zurück zum Zitat Truant S, Sequier C, Leteurtre E, Boleslawski E, Elamrani M, Huet G, et al. Tumor biology of colorectal liver metastasis is a more important factor in survival than surgical margin clearance in the era of modern chemotherapy regimens. HPB (Oxford) 2015;17:176–184.CrossRef Truant S, Sequier C, Leteurtre E, Boleslawski E, Elamrani M, Huet G, et al. Tumor biology of colorectal liver metastasis is a more important factor in survival than surgical margin clearance in the era of modern chemotherapy regimens. HPB (Oxford) 2015;17:176–184.CrossRef
18.
Zurück zum Zitat Margonis GA, Sasaki K, Kim Y, Samaha M, Buettner S, Amini N, et al. Tumor biology rather than surgical technique dictates prognosis in colorectal cancer liver metastases. J Gastrointest Surg. 2016;20:1821–1829.CrossRefPubMed Margonis GA, Sasaki K, Kim Y, Samaha M, Buettner S, Amini N, et al. Tumor biology rather than surgical technique dictates prognosis in colorectal cancer liver metastases. J Gastrointest Surg. 2016;20:1821–1829.CrossRefPubMed
19.
Zurück zum Zitat Margonis GA, Sasaki K, Andreatos N, Kim Y, Merath K, Wagner D, et al. KRAS mutation status dictates optimal surgical margin width in patients undergoing resection of colorectal liver metastases. Ann Surg Oncol. 2017;24:264–271.CrossRefPubMed Margonis GA, Sasaki K, Andreatos N, Kim Y, Merath K, Wagner D, et al. KRAS mutation status dictates optimal surgical margin width in patients undergoing resection of colorectal liver metastases. Ann Surg Oncol. 2017;24:264–271.CrossRefPubMed
20.
Zurück zum Zitat Pawlik TM, Scoggins CR, Zorzi D, Abdalla EK, Andres A, Eng C, et al. Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg. 2005;241:715–724.CrossRefPubMedPubMedCentral Pawlik TM, Scoggins CR, Zorzi D, Abdalla EK, Andres A, Eng C, et al. Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg. 2005;241:715–724.CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Bodingbauer M, Tamandl D, Schmid K, Plamk C, Schima W, Gruenberger T. Size of surgical margin does not influence recurrence rates after curative liver resection for colorectal cancer liver metastases. Br J Surg. 2007;94:1133–1138.CrossRefPubMed Bodingbauer M, Tamandl D, Schmid K, Plamk C, Schima W, Gruenberger T. Size of surgical margin does not influence recurrence rates after curative liver resection for colorectal cancer liver metastases. Br J Surg. 2007;94:1133–1138.CrossRefPubMed
22.
Zurück zum Zitat Muratore A, Ribero D, Zimmitti G, Mellano A, Lamgella S, Capussotti L. Resection margin and recurrence-free survival after liver resection of colorectal metastases. Ann Surg Oncol. 2010;17:1324–1329.CrossRefPubMed Muratore A, Ribero D, Zimmitti G, Mellano A, Lamgella S, Capussotti L. Resection margin and recurrence-free survival after liver resection of colorectal metastases. Ann Surg Oncol. 2010;17:1324–1329.CrossRefPubMed
23.
Zurück zum Zitat Eveno C, Karoui M, Gayet E, Luciani A, Auriault ML, Kluger MD, et al. Liver resection for colorectal livermetastases with peri-operative chemotherapy: oncological results of R1 resection. HPB (Oxford). 2013;15:359–364.CrossRef Eveno C, Karoui M, Gayet E, Luciani A, Auriault ML, Kluger MD, et al. Liver resection for colorectal livermetastases with peri-operative chemotherapy: oncological results of R1 resection. HPB (Oxford). 2013;15:359–364.CrossRef
24.
Zurück zum Zitat Tanaka K, Nojiri K, Kumamoto T, Takeda K, Endo I. R1 resection for aggressive or advanced colorectal liver metastases is justified in combination with effective prehepatectomy chemotherapy. Eur J Surg Oncol. 2011;37:336–343.CrossRefPubMed Tanaka K, Nojiri K, Kumamoto T, Takeda K, Endo I. R1 resection for aggressive or advanced colorectal liver metastases is justified in combination with effective prehepatectomy chemotherapy. Eur J Surg Oncol. 2011;37:336–343.CrossRefPubMed
25.
Zurück zum Zitat Sasaki K, Margonis GA, Andreatos N, Wilson A, Weiss M, Wolfgang C, et al. Prognostic impact of margin status in liver resections for colorectal metastases after bevacizumab. Br J Surg. 2017;104:926–935.CrossRefPubMed Sasaki K, Margonis GA, Andreatos N, Wilson A, Weiss M, Wolfgang C, et al. Prognostic impact of margin status in liver resections for colorectal metastases after bevacizumab. Br J Surg. 2017;104:926–935.CrossRefPubMed
26.
Zurück zum Zitat Sasaki K, Morioka D, Conci S, Margonis GA, Sawada Y, Ruzzenente A, et al. The Tumor Burden Score: a new “metro-ticket” prognostic tool for colorectal liver metastases based on tumor size and number of tumors. Ann Surg. 2018;267:132–141.CrossRefPubMed Sasaki K, Morioka D, Conci S, Margonis GA, Sawada Y, Ruzzenente A, et al. The Tumor Burden Score: a new “metro-ticket” prognostic tool for colorectal liver metastases based on tumor size and number of tumors. Ann Surg. 2018;267:132–141.CrossRefPubMed
27.
Zurück zum Zitat Tanaka K, Hiroshima Y, Nakagawa K, Kumamoto T, Nojiri K, Takeda K, et al. Two-stage hepatectomy with effective perioperative chemotherapy does not induce tumor growth or growth factor expression in liver metastases from colorectal cancer. Surgery 2013;153:179–188.CrossRefPubMed Tanaka K, Hiroshima Y, Nakagawa K, Kumamoto T, Nojiri K, Takeda K, et al. Two-stage hepatectomy with effective perioperative chemotherapy does not induce tumor growth or growth factor expression in liver metastases from colorectal cancer. Surgery 2013;153:179–188.CrossRefPubMed
28.
Zurück zum Zitat Compton CC. Key issue in reporting common cancer specimens: problems in pathologic staging of colon cancer. Arch Pathol Lab Med. 2006;130:318–324.PubMed Compton CC. Key issue in reporting common cancer specimens: problems in pathologic staging of colon cancer. Arch Pathol Lab Med. 2006;130:318–324.PubMed
29.
Zurück zum Zitat Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45:228–247.CrossRefPubMed Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45:228–247.CrossRefPubMed
30.
Zurück zum Zitat Strasberg SM, Belghiti J, Clavien PA, Gadzijev E, Garden JO, Lau WY, et al. The Brisbane 2000 terminology of liver anatomy and resections. HPB. 2000;2:333–339.CrossRef Strasberg SM, Belghiti J, Clavien PA, Gadzijev E, Garden JO, Lau WY, et al. The Brisbane 2000 terminology of liver anatomy and resections. HPB. 2000;2:333–339.CrossRef
31.
Zurück zum Zitat Sasaki K, Margonis GA, Andreatos N, Wilson A, Gani F, Amini N, et al. Pre-hepatectomy carcinoembryonic antigen (CEA) levels among patients undergoing resection of colorectal liver metastases: do CEA levels still have prognostic implications? HPB (Oxford). 2016;18:1000–1009.CrossRef Sasaki K, Margonis GA, Andreatos N, Wilson A, Gani F, Amini N, et al. Pre-hepatectomy carcinoembryonic antigen (CEA) levels among patients undergoing resection of colorectal liver metastases: do CEA levels still have prognostic implications? HPB (Oxford). 2016;18:1000–1009.CrossRef
32.
Zurück zum Zitat Sasaki K, Margonis GA, Wilson A, Kim Y, Buettner S, Andreatos N, et al. Prognostic implication of KRAS status after hepatectomy for colorectal liver metastases varies according to primary colorectal tumor location. Ann Surg Oncol. 2016;23:3736–3743.CrossRefPubMed Sasaki K, Margonis GA, Wilson A, Kim Y, Buettner S, Andreatos N, et al. Prognostic implication of KRAS status after hepatectomy for colorectal liver metastases varies according to primary colorectal tumor location. Ann Surg Oncol. 2016;23:3736–3743.CrossRefPubMed
33.
Zurück zum Zitat Sasaki K, Margonis GA, Andreatos N, Zhang XF, Buettner S, Wang J, et al. The prognostic utility of the “Tumor Burden Score” based on preoperative radiographic features of colorectal liver metastases. J Surg Oncol. 2017;116:515–523.CrossRefPubMed Sasaki K, Margonis GA, Andreatos N, Zhang XF, Buettner S, Wang J, et al. The prognostic utility of the “Tumor Burden Score” based on preoperative radiographic features of colorectal liver metastases. J Surg Oncol. 2017;116:515–523.CrossRefPubMed
Metadaten
Titel
Higher Tumor Burden Neutralizes Negative Margin Status in Hepatectomy for Colorectal Cancer Liver Metastasis
verfasst von
Masanori Oshi, MD
Georgios Antonios Margonis, MD, PhD
Yu Sawada, MD, PhD
Nikolaos Andreatos, MD
Jin He, MD, PhD
Takafumi Kumamoto, MD, PhD
Daisuke Morioka, MD, PhD
Christopher Lee Wolfgang, MD, PhD
Kuniya Tanaka, MD, PhD
Matthew John Weiss, MD
Itaru Endo, MD, PhD
Publikationsdatum
27.11.2018
Verlag
Springer International Publishing
Erschienen in
Annals of Surgical Oncology / Ausgabe 2/2019
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-018-6830-x

Weitere Artikel der Ausgabe 2/2019

Annals of Surgical Oncology 2/2019 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.